StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a research report released on Wednesday. The brokerage issued a sell rating on the stock. Separately, Needham & Company LLC cut their price target on shares of OncoCyte from $1.40 to $0.45 and set a buy rating on the stock in a research […] The post StockNews.com Begins Coverage on OncoCyte (NASDAQ:OCX) first appeared on Daily Political .

https://www.dailypolitical.com/2023/07/23/stocknews-com-begins-coverage-on-oncocyte-nasdaqocx.html

#dailypolitical